Celldex Therapeutics, Inc. (CLDX)
NASDAQ: CLDX · Real-Time Price · USD
18.48
-1.04 (-5.35%)
May 9, 2025, 3:48 PM - Market open

Celldex Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-178.85-157.86-141.43-112.33-70.51-59.78
Upgrade
Depreciation & Amortization
3.273.183.012.93.073.93
Upgrade
Loss (Gain) From Sale of Assets
0.010.02-0-0.02-0.06
Upgrade
Asset Writedown & Restructuring Costs
----3.518
Upgrade
Loss (Gain) From Sale of Investments
-14.7-15.75-6.220.84-3.21-0.73
Upgrade
Stock-Based Compensation
36.3634.2423.8915.618.953.92
Upgrade
Other Operating Activities
----6.86-1.63-5.39
Upgrade
Change in Accounts Receivable
1.611.93-2.28-0.181.57-0.79
Upgrade
Change in Accounts Payable
7.711.639.383.123.651.64
Upgrade
Change in Other Net Operating Assets
-26.9-35.166.36-6.85-6.28-1.15
Upgrade
Operating Cash Flow
-171.51-157.78-107.29-103.73-60.91-40.4
Upgrade
Capital Expenditures
-1.84-1.92-1.82-1.83-1.25-1.55
Upgrade
Sale of Property, Plant & Equipment
---0.070.030.06
Upgrade
Investment in Securities
69.87-288.21-103.9691.7-214.93-96.72
Upgrade
Investing Cash Flow
68.03-290.13-105.7889.94-216.16-98.22
Upgrade
Short-Term Debt Issued
-----2.96
Upgrade
Total Debt Issued
-----2.96
Upgrade
Short-Term Debt Repaid
------2.96
Upgrade
Total Debt Repaid
------2.96
Upgrade
Issuance of Common Stock
5.54441.45218.464.08272.37171.23
Upgrade
Financing Cash Flow
5.54441.45218.464.08272.37171.23
Upgrade
Net Cash Flow
-97.94-6.465.39-9.71-4.6932.6
Upgrade
Free Cash Flow
-173.35-159.7-109.11-105.56-62.16-41.96
Upgrade
Free Cash Flow Margin
-2293.32%-2274.89%-1585.19%-4478.57%-1336.44%-565.60%
Upgrade
Free Cash Flow Per Share
-2.62-2.48-2.25-2.25-1.45-1.42
Upgrade
Levered Free Cash Flow
-103.2-91.67-46.7-58.03-29.71-22.62
Upgrade
Unlevered Free Cash Flow
-103.2-91.67-46.7-58.03-29.71-22.62
Upgrade
Change in Net Working Capital
3.125.25-16.997.77-2.74-2.07
Upgrade
Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q